"/> Invitrogen™ Peptide synthétique LZTR2 humain | B-LABO France

Invitrogen™ Peptide synthétique LZTR2 humain

Réf. : BL-RE-175989Réf. fabricant : 15235019 50 μg
137,00 € HT

Synthetic Peptide

Gene ID (Entrez)
89866
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
Q96JE7
Nom usuel
Human LZTR2
Marque
Invitrogen

LZTR2 Synthetic Peptide, PEP-1017, from Invitrogen.

LZTR2, also known as RGPR-p117, is a member of the BTB-kelch superfamily and was initially described as a nuclear factor I (NFI) binding protein and transcriptional regulator of the regucalcin gene. LZTR2 is cytoplasmically localized but is thought to translocate to the nucleus, a process mediated by protein kinase C signaling following hormonal stimulation. Recent evidence has suggested that there is a strong correlation of single nucleotide polymorphisms of LZTR2 with obesity in the Japanese population similar to that seen with the TMEM18 gene and the GNPDA2, BDNF, FAIM2, and MC4R genes with obesity in Caucasian populations, suggesting LZTR2 may play a role in metabolism and obesity risk.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-175989
Réf. fabricant15235019
Gene ID (Entrez)89866
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionQ96JE7
Nom usuelHuman LZTR2
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)SEC16B
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.